217 related articles for article (PubMed ID: 31604427)
1. Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm.
Karki R; Kodamullil AT; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2019 Oct; 20(1):494. PubMed ID: 31604427
[TBL] [Abstract][Full Text] [Related]
2. Comparing Alzheimer's and Parkinson's diseases networks using graph communities structure.
Calderone A; Formenti M; Aprea F; Papa M; Alberghina L; Colangelo AM; Bertolazzi P
BMC Syst Biol; 2016 Mar; 10():25. PubMed ID: 26935435
[TBL] [Abstract][Full Text] [Related]
3. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
[TBL] [Abstract][Full Text] [Related]
4. Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease.
Kelly J; Moyeed R; Carroll C; Albani D; Li X
Mol Brain; 2019 Feb; 12(1):16. PubMed ID: 30819229
[TBL] [Abstract][Full Text] [Related]
5. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
[TBL] [Abstract][Full Text] [Related]
6. Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis.
Shi Y; Liu W; Yang Y; Ci Y; Shi L
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902271
[TBL] [Abstract][Full Text] [Related]
7. The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs).
Limviphuvadh V; Tanaka S; Goto S; Ueda K; Kanehisa M
Bioinformatics; 2007 Aug; 23(16):2129-38. PubMed ID: 17553855
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
9. Network-Based Analysis for Uncovering Mechanisms Underlying Alzheimer's Disease.
Kikuchi M; Ogishima S; Mizuno S; Miyashita A; Kuwano R; Nakaya J; Tanaka H
Methods Mol Biol; 2016; 1303():479-91. PubMed ID: 26235086
[TBL] [Abstract][Full Text] [Related]
10. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
11. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.
Wang Q; Li WX; Dai SX; Guo YC; Han FF; Zheng JJ; Li GH; Huang JF
J Alzheimers Dis; 2017; 56(4):1525-1539. PubMed ID: 28222515
[TBL] [Abstract][Full Text] [Related]
13. An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases.
Li P; Nie Y; Yu J
PLoS One; 2015; 10(11):e0143045. PubMed ID: 26575483
[TBL] [Abstract][Full Text] [Related]
14. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
George G; Valiya Parambath S; Lokappa SB; Varkey J
Gene; 2019 May; 697():67-77. PubMed ID: 30776463
[TBL] [Abstract][Full Text] [Related]
15. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
17. Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.
Turkez H; Altay O; Yildirim S; Li X; Yang H; Bayram C; Bolat I; Oner S; Tozlu OO; Arslan ME; Arif M; Yulug B; Hanoglu L; Cankaya S; Lam S; Velioglu HA; Coskun E; Idil E; Nogaylar R; Ozsimsek A; Hacimuftuoglu A; Shoaie S; Zhang C; Nielsen J; Borén J; Uhlén M; Mardinoglu A
Life Sci; 2023 Feb; 314():121325. PubMed ID: 36581096
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in neurodegenerative disorder research in China.
Zhou J
Sci China Life Sci; 2010 Mar; 53(3):348-355. PubMed ID: 20596930
[TBL] [Abstract][Full Text] [Related]
19. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
[TBL] [Abstract][Full Text] [Related]
20. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases.
Wu YR; Fung HC; Lee-Chen GJ; Gwinn-Hardy K; Ro LS; Chen ST; Hsieh-Li HM; Lin HY; Lin CY; Li SN; Chen CM
J Neural Transm (Vienna); 2005 Apr; 112(4):539-46. PubMed ID: 15365789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
